Clinical Trial Update: Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 randomized trial comparing ixabepilone plus capecitabine versus docetaxel plus capecitabine for metastatic breast cancer was terminated; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ixabepilone (ixabepilone)
• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: R-Pharm | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2011-06-01